B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 700 KRW 1.99% Market Closed
Market Cap: 433.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

BioPlus Co Ltd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioPlus Co Ltd
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Other Equity
â‚©2B
CAGR 3-Years
0%
CAGR 5-Years
25%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Other Equity
â‚©59.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Other Equity
-â‚©183.5B
CAGR 3-Years
6%
CAGR 5-Years
-119%
CAGR 10-Years
-29%
T
T&L Co Ltd
KOSDAQ:340570
Other Equity
â‚©259.1m
CAGR 3-Years
46%
CAGR 5-Years
25%
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Other Equity
â‚©1.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Other Equity
â‚©2.5B
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
39%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433.5B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B

See Also

What is BioPlus Co Ltd's Other Equity?
Other Equity
2B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Other Equity amounts to 2B KRW.

What is BioPlus Co Ltd's Other Equity growth rate?
Other Equity CAGR 5Y
25%

Over the last year, the Other Equity growth was -25%.

Back to Top